TGF-β1 signaling plays a dominant role in the crosstalk between TGF-β1 and the aryl hydrocarbon receptor ligand in prostate epithelial cells

Cellular Signalling

Volumn 24, Issue 8, 2012, Pages 1665-1676

  Staršíchová, Andrea ^a,e   Hrubá, Eva ^b   Slabáková, Eva ^a,c   Pernicová, Zuzana ^a,c,d   Procházková, Jiřina ^a,b   Pěnčíková, Kateřina ^b   Šeda, Václav ^a,d   Kabátková, Markéta ^a,d   Vondráček, Jan ^a,b   Kozubík, Alois ^a,d   Machala, Miroslav ^b   Souček, Karel ^a,c  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b VETERINARY RESEARCH INSTITUTE   (Czech Republic)

^c ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^d MASARYK UNIVERSITY   (Czech Republic)

^e UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

2,3,7,8 Tetrachlorodibenzo p dioxin; Aryl hydrocarbon receptor; Prostate epithelial cells; SMAD4; Transforming growth factor

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; MESSENGER RNA; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; ARYL HYDROCARBON RECEPTOR GENE; CELLULAR DISTRIBUTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOCHROME P450 CYP1A1 GENE; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; HUMAN CELL; LIGAND BINDING; MALE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; TISSUE METABOLISM;

CELLS, CULTURED; EPITHELIAL CELLS; HUMANS; LIGANDS; MALE; PROSTATE; RECEPTORS, ARYL HYDROCARBON; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TETRACHLORODIBENZODIOXIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84861549252     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2012.04.008     Document Type: Article

References (64)

1. McIntosh B.E., Hogenesch J.B., Bradfield C.A. Annual Review of Physiology 2010, 72:625-645.
2. Denison M.S., Nagy S.R. Annual Review of Pharmacology and Toxicology 2003, 43:309-334.
3. Nguyen L.P., Bradfield C.A. Chemical Research in Toxicology 2008, 21:102-116.
4. Hahn M.E., Allan L.L., Sherr D.H. Biochemical Pharmacolog 2009, 77:485-497.
5. Abel J., Haarmann-Stemmann T. Biological Chemistry 2010, 391:1235-1248.
6. Ma Q., Baldwin K.T. Journal of Biological Chemistry 2000, 275:8432-8438.
7. Xu C., Li C.Y., Kong A.N. Archives of Pharmacal Research 2005, 28:249-268.
8. Huang G., Elferink C.J. Molecular Pharmacology 2012, 81:338-347.
9. Hsieh T.H., Tsai C.F., Hsu C.Y., Kuo P.L., Lee J.N., Chai C.Y., Wang S.C., Tsai E.M. The FASEB Journal 2011, 26:778-787.
10. Ohtake F., Baba A., Takada I., Okada M., Iwasaki K., Miki H., Takahashi S., Kouzmenko A., Nohara K., Chiba T., Fujii-Kuriyama Y., Kato S. Nature 2007, 446:562-566.
11. Puga A., Ma C., Marlowe J.L. Biochemical Pharmacology 2009, 77:713-722.
12. Haarmann-Stemmann T., Bothe H., Abel J. Biochemical Pharmacology 2009, 77:508-520.
13. Ma C., Marlowe J.L., Puga A. EXS 2009, 99:231-257.
14. Vondracek J., Umannova L., Machala M. Current Drug Metabolism 2011, 12:89-103.
15. Letterio J.J., Roberts A.B. Annual Review of Immunology 1998, 16:137-161.
16. Siegel P.M., Massague J. Nature Reviews. Cancer 2003, 3:807-820.
17. Kang Y., Massague J. Cell 2004, 118:277-279.
18. Massague J. Cell 2008, 134:215-230.
19. Massague J. Annual Review of Biochemistry 1998, 67:753-791.
20. Massague J. Nature Reviews. Molecular Cell Biology 2000, 1:169-178.
21. Quintana F.J., Basso A.S., Iglesias A.H., Korn T., Farez M.F., Bettelli E., Caccamo M., Oukka M., Weiner H.L. Nature 2008, 453:65-71.
22. Chang X., Fan Y., Karyala S., Schwemberger S., Tomlinson C.R., Sartor M.A., Puga A. Molecular and Cellular Biology 2007, 27:6127-6139.
23. Santiago-Josefat B., Mulero-Navarro S., Dallas S.L., Fernandez-Salguero P.M. Journal of Cell Science 2004, 117:849-859.
24. Carvajal-Gonzalez J.M., Roman A.C., Cerezo-Guisado M.I., Rico-Leo E.M., Martin-Partido G., Fernandez-Salguero P.M. Journal of Cell Science 2009, 122:1823-1833.
25. Jin M.H., Hong C.H., Lee H.Y., Kang H.J., Han S.W. Toxicology Letters 2008, 178:202-209.
26. Döhr O., Sinning R., Vogel C., Munzel P., Abel J. Molecular Pharmacology 1997, 51:703-710.
27. Döhr O., Abel J. Biochemical and Biophysical Research Communications 1997, 241:86-91.
28. Muller G.F., Dohr O., El-Bahay C., Kahl R., Abel J. Archives of Toxicology 2000, 74:145-152.
29. Roman A.C., Carvajal-Gonzalez J.M., Rico-Leo E.M., Fernandez-Salguero P.M. Journal of Biological Chemistry 2009, 284:25135-25148.
30. Mezrich J.D., Fechner J.H., Zhang X., Johnson B.P., Burlingham W.J., Bradfield C.A. Journal of Immunology 2011, 185:3190-3198.
31. Veldhoen M., Hirota K., Westendorf A.M., Buer J., Dumoutier L., Renauld J.C., Stockinger B. Nature 2008, 453:106-109.
32. Platzer B., Richter S., Kneidinger D., Waltenberger D., Woisetschlager M., Strobl H. Journal of Immunology 2009, 183:66-74.
33. Vezina C.M., Lin T.-M., Peterson R.E. Biochemical Pharmacology 2009, 77:566-576.
34. Fritz W.A., Lin T.-M., Cardiff R.D., Peterson R.E. Carcinogenesis 2007, 28:497-505.
35. Vezina C.M., Allgeier S.H., Moore R.W., Lin T.M., Bemis J.C., Hardin H.A., Gasiewicz T.A., Peterson R.E. Toxicological Sciences 2008, 106:488-496.
36. Mehta V., Vezina C.M. Differentiation 2011, 82:211-219.
37. Hayward S., Dahiya R., Cunha G., Bartek J., Deshpande N., Narayan P. In Vitro Cellular & Developmental Biology. Animal 1995, 31:14-24.
38. Livak K.J., Schmittgen T.D. Methods 2001, 25:402-408.
39. Sanderson J.T., Aarts J.M.M.J.G., Brouwer A., Froese K.L., Denison M.S., Giesy J.P. Toxicology and Applied Pharmacology 1996, 137:316-325.
40. Lehmann G.M., Xi X., Kulkarni A.A., Olsen K.C., Pollock S.J., Baglole C.J., Gupta S., Casey A.E., Huxlin K.R., Sime P.J., Feldon S.E., Phipps R.P. American Journal of Pathology 2011, 178:1556-1567.
41. Gramatzki D., Pantazis G., Schittenhelm J., Tabatabai G., Kohle C., Wick W., Schwarz M., Weller M., Tritschler I. Oncogene 2009, 28:2593-2605.
42. Slabakova E., Pernicova Z., Slavickova E., Starsichova A., Kozubik A., Soucek K. The Prostate 2011, 71:1332-1343.
43. Starsichova A., Kubala L., Lincova E., Pernicova Z., Kozubik A., Soucek K. Biological Procedures Online 2009.
44. Starsíchová A., Lincová E., Pernicová Z., Kozubík A., Soucek K. Cellular Signalling 2010, 22:1734-1744.
45. Wenner C.E., Yan S. Journal of Cellular Physiology 2003, 196:42-50.
46. Sutkowski D.M., Fong C.-J., Sensibar J.A., Rademaker A.W., Sherwood E.R., Kozlowski J.M., Lee C. The Prostate 1992, 21:133-143.
47. Wolff S., Harper P.A., Wong J.M.Y., Mostert V., Wang Y., Abel J. Molecular Pharmacology 2001, 59:716-724.
48. Koelink P.J., Hawinkels L.J.A.C., Wiercinska E., Sier C.F.M., Dijke Pt, Lamers C.B.H.W., Hommes D.W., Verspaget H.W. Cancer Letters 2010, 287:82-90.
49. Gomez-Duran A., Carvajal-Gonzalez J.M., Mulero-Navarro S., Santiago-Josefat B., Puga A., Fernandez-Salguero P.M. Biochemical Pharmacology 2009, 77:700-712.
50. Morrow D., Qin C., Smith R., Safe S. The Journal of Steroid Biochemistry and Molecular Biology 2004, 88:27-36.
51. Barnes-Ellerbe S., Knudsen K.E., Puga A. Molecular Pharmacology 2004, 66:502-511.
52. Chamie K., deVere White R.W., Lee D., Ok J., Ellison L.M. Cancer 2008, 113:2464-2470.
53. Schecter A., Needham L., Pavuk M., Michalek J., Colacino J., Ryan J., Päpke O., Birnbaum L. Cancer 2009, 115:3369-3371.
54. Shah S.R., Terris M.K. Cancer 2008, 113:2382-2384.
55. Boffetta P., Mundt K.A., Adami H.O., Cole P., Mandel J.S. Critical Reviews in Toxicology 2011, 41:622-636.
56. Kasai A., Hiramatsu N., Hayakawa K., Yao J., Maeda S., Kitamura M. Cancer Research 2006, 66:7143-7150.
57. Huncharek M., Haddock K.S., Reid R., Kupelnick B. American Journal of Public Health 2010, 100:693-701.
58. Kenfield S.A., Stampfer M.J., Chan J.M., Giovannucci E. JAMA: The Journal of the American Medical Association 2011, 305:2548-2555.
59. Rybicki B.A., Neslund-Dudas C., Bock C.H., Rundle A., Savera A.T., Yang J.J., Nock N.L., Tang D. Clinical Cancer Research 2008, 14:750-757.
60. Pollenz R.S. Chemico-Biological Interactions 2002, 141:41-61.
61. Song Z., Pollenz R.S. Molecular Pharmacology 2002, 62:806-816.
62. Prochazkova J., Kozubik A., Machala M., Vondracek J. Toxicology 2011, 279:146-154.
63. Guo J., Sartor M., Karyala S., Medvedovic M., Kann S., Puga A., Ryan P., Tomlinson C.R. Toxicology and Applied Pharmacology 2004, 194:79-89.
64. Sutter C.H., Yin H., Li Y., Mammen J.S., Bodreddigari S., Stevens G., Cole J.A., Sutter T.R. Proceedings of the National Academy of Sciences 2009, 106:4266-4271.